Literature DB >> 17310253

Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility.

Mingxuan Xia1, Hartmut Land.   

Abstract

Many features of the cancer cell phenotype emerge as a result of cooperation between multiple oncogenic mutations. Here we show that activated Ras(V12) and loss of p53 function can cooperate to promote cell motility, a feature closely associated with cancer progression to malignancy. Our analysis indicates that Ras(V12) and loss of p53 synergistically induce RhoA activity, revealing a previously unknown role for p53 in tumor suppression. p53 prevents activation of RhoA and thus induction of cell motility by Ras(V12) through a simple signaling circuit, which integrates multiple inputs that converge on RhoA. Our data suggest that p53 suppresses cancer progression to malignancy by modulating the quality of Ras signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17310253     DOI: 10.1038/nsmb1208

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  55 in total

1.  Transcriptional regulation of Rho GTPase signaling.

Authors:  Daniel R Croft; Michael F Olson
Journal:  Transcription       Date:  2011 Sep-Oct

2.  Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion.

Authors:  Utpal K Mukhopadhyay; Patrick Mooney; Lilly Jia; Robert Eves; Leda Raptis; Alan S Mak
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

3.  A transcription co-factor integrates cell adhesion and motility with the p53 response.

Authors:  Amanda S Coutts; Louise Weston; Nicholas B La Thangue
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

4.  p53 protects against LPS-induced lung endothelial barrier dysfunction.

Authors:  Nektarios Barabutis; Christiana Dimitropoulou; Charalampos Birmpas; Atul Joshi; Gagan Thangjam; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-02-20       Impact factor: 5.464

5.  Inhibition of MLC phosphorylation restricts replication of influenza virus--a mechanism of action for anti-influenza agents.

Authors:  Mehran Haidari; Wei Zhang; Leila Ganjehei; Muzammil Ali; Zhenping Chen
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

6.  Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.

Authors:  John M Ashton; Marlene Balys; Sarah J Neering; Duane C Hassane; Glenn Cowley; David E Root; Peter G Miller; Benjamin L Ebert; Helene R McMurray; Hartmut Land; Craig T Jordan
Journal:  Cell Stem Cell       Date:  2012-08-02       Impact factor: 24.633

7.  Fitting Boolean networks from steady state perturbation data.

Authors:  Anthony Almudevar; Matthew N McCall; Helene McMurray; Hartmut Land
Journal:  Stat Appl Genet Mol Biol       Date:  2011-10-05

8.  Eukaryotic Translation Initiation Factor 5A (EIF5A) Regulates Pancreatic Cancer Metastasis by Modulating RhoA and Rho-associated Kinase (ROCK) Protein Expression Levels.

Authors:  Ken Fujimura; Sunkyu Choi; Meghan Wyse; Jan Strnadel; Tracy Wright; Richard Klemke
Journal:  J Biol Chem       Date:  2015-10-19       Impact factor: 5.157

Review 9.  Contribution of p53 to metastasis.

Authors:  Emily Powell; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Cancer Discov       Date:  2014-03-21       Impact factor: 39.397

10.  Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation.

Authors:  Hsiao-Ling Cheng; Shu-Jem Su; Li-Wen Huang; Bau-Shan Hsieh; Yu-Chen Hu; Thu-Ching Hung; Kee-Lung Chang
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.